2. U.S. Food and Drug Administration. ‘Frequently Asked Questions: Breakthrough Therapies.’ Available at: Accessed on, may 28, 2014. 3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. Ca Tumor J Clin. 2013;63:11-30. 4. Gatta G, Maarten van der Zwan J, Casali P, et. Al. Rare cancers aren’t so rare: The rare cancer burden in European countries. Eur J Cancer. 2011;47:2493-2511. 5. Advani A.S. New immune approaches for the treatment of acute lymphoblastic leukemia: Antibodies and chimeric antigen receptors. Hematology Am Soc Hematol Educ Program. 2013;2013:131-7. Retrieved from: 6. Mayo Clinic. ‘Acute lymphocytic leukemia: symptoms’. Offered by: Accessed on, may 28, 2014.. One key point of contention focuses on a measure authorized last month by House Republicans to trim $1.6 billion in funding for the united states National Institutes of Health for the rest of the fiscal year.2 billion spending budget smooth, while President Barack Obama proposed a $750 million improve for the agency next year.The CDC is definitely distributing the much sought-after vaccine to Wall Street firms despite reviews of vast shortages. In fact, yesterday CDC Director Thomas Frieden informed Congress that just 32 just.3 million doses are available, far less than the 159 million had a need to cover those at the highest risk. Provided the scarce source, the CDC has suggested the vaccine become directed only to those at highest risk: women that are pregnant, infants and children and those up to 24 years, those who look after infants, emergency and health services personnel, and adults with compromised immune systems or various other chronic health problems.